RLMD Return on Tangible Equity | RELMADA THERAPEUTICS, INC.

RELMADA THERAPEUTICS, INC. (RLMD) Return on Tangible Equity

2026-06-30: Return Tang Equity -29.98%.
2026-03-31: Return Tang Equity -26.92%.
2025-12-31: Return Tang Equity -66.33%.
2025-09-30: Return Tang Equity -593.46%.

Complete source-backed return tang equity history.

Available history: 2012-08-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-29.98%
2026-03-31	-26.92%
2025-12-31	-66.33%
2025-09-30	-593.46%
2025-06-30	-425.15%
2025-03-31	-337.38%
2024-12-31	-225.15%
2024-09-30	-181.60%
2024-06-30	-141.10%
2024-03-31	-130.89%
2023-12-31	-115.74%
2023-09-30	-110.77%
2023-06-30	-115.85%
2023-03-31	-114.47%
2022-12-31	-111.83%
2022-09-30	-92.26%
2022-06-30	-79.59%
2022-03-31	-68.10%
2021-12-31	-60.38%
2021-09-30	-154.27%
2021-06-30	-89.24%
2021-03-31	-77.89%
2020-12-31	-56.31%
2020-09-30	-35.37%
2020-06-30	-22.68%
2020-03-31	-20.32%
2019-12-31	-12.97%
2019-09-30	-294.57%
2019-06-30	-227.47%
2019-03-31	-3491.34%
2018-12-31	-1189.20%
2018-09-30	130.85%
2018-06-30	162.54%
2018-03-31	312.80%
2017-12-31	-835.34%
2017-09-30	-384.23%
2017-06-30	-430.50%
2017-03-31	-284.45%
2016-12-31	-167.89%
2016-09-30	-166.46%
2016-06-30	-42.24%
2016-03-31	62.57%
2015-12-31	49.15%
2015-09-30	99.01%
2015-06-30	-236.14%
2015-03-31	-816.06%
2014-12-31	-502.02%
2014-09-30	137.66%
2013-12-31	37.65%
2013-11-30	5711.45%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-66.33%
2024-12-31	-225.15%
2023-12-31	-115.74%
2022-12-31	-111.83%
2021-12-31	-60.38%
2020-12-31	-56.31%
2019-12-31	-12.97%
2019-06-30	-227.47%
2018-06-30	162.54%
2017-06-30	-430.50%
2016-06-30	-42.24%
2015-06-30	-236.14%
2013-12-31	110.71%
2013-08-31	329.61%
2012-08-31	-106.11%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63